Morphea, also known as localized
sclerodermaScleroderma
Scleroderma - resources, is a
disorderAdjustment disorder
Anorexia nervosa
Asperger syndrome
Attention deficit hyperactivity disorder (adhd)
Autism
Autoimmune disorders
Bipolar disorder
Bipolar disorder
Bleeding disorders
Borderline personality disorder
Bulimia characterized by thickening and induration of the
skinActinic keratosis
Aging changes in skin
Allergy skin prick or scratch test
Allergy testing
Basal cell carcinoma
Birthmarks - red
Cellulitis
Circumcision
Cutaneous skin tags
Dry skin
Fair skin cancer risks and subcutaneous tissue due to excessive collagen deposition. Morphea subtypes are classified according to their clinical presentation and depth of tissue involvement; they include
plaqueArterial plaque build-up
Atherosclerosis
Plaque and tartar on teeth
Plaque buildup in arteries
Progressive build-up of plaque in coronary artery
Psoriasis-type,
generalizedGeneralized anxiety disorder, linear, and deep varieties. Unlike
systemicSystemic lupus erythematosus
Systemic lupus erythematosus rash on the face sclerosisAmyotrophic lateral sclerosis
Arteriosclerosis of the extremities
Atherosclerosis
Atherosclerosis of internal carotid artery
Atherosclerosis of the extremities
Developmental process of atherosclerosis
Diabetic nephropathy
Enlarged view of atherosclerosis
Multiple sclerosis
Multiple sclerosis - resources
Otosclerosis, morphea lacks features, such as sclerodactyly,
RaynaudRaynaud's phenomenon phenomenonRaynaud's phenomenon
Raynaud’s phenomenon, and internal organ involvement.
Most
patientsKidney diet - dialysis patients with
plaqueArterial plaque build-up
Atherosclerosis
Plaque and tartar on teeth
Plaque buildup in arteries
Progressive build-up of plaque in coronary artery
Psoriasis-type morphea experience very gradual (eg, over 3-5 y) spontaneous remission. Therapy with topical or intralesional corticosteroids offers little or limited benefit. Treatment with topical
calcipotrieneCalcipotriene topical may be attempted.
PatientsKidney diet - dialysis patients with
generalizedGeneralized anxiety disorder, linear, and deep morphea may require more aggressive therapy.
PhysicalPhysical activity
Physical exam frequency
Physical examination therapy to preserve range of motion is of utmost importance. Numerous
therapeuticAbortion - elective or therapeutic agents have been used, including
systemicSystemic lupus erythematosus
Systemic lupus erythematosus rash on the face corticosteroids, antimalarial agents, D-
penicillamine, and other anti-
inflammatoryCrohn's disease
Inflammatory bowel disease
Ulcerative colitis and immunosuppressive agents. However, no large randomized studies of these agents in
patientsKidney diet - dialysis patients with morphea exist.
The use of low-dose UV-A phototherapy has produced marked clinical improvement of treated morphea
lesionsAcne - close-up of pustular lesions
Bone lesion biopsy
Chickenpox - lesion on the leg
Chickenpox - lesions on the chest
Erythema multiforme, circular lesions - hands
Erythema multiforme, target lesions on the palm
Gram stain of skin lesion
Herpes zoster (shingles) - close-up of lesion
Janeway lesion - close-up
Janeway lesion on the finger
Kaposi's sarcoma - lesion on the foot. PUVA bath photochemotherapy has also been reported to be helpful in
patientsKidney diet - dialysis patients with
plaqueArterial plaque build-up
Atherosclerosis
Plaque and tartar on teeth
Plaque buildup in arteries
Progressive build-up of plaque in coronary artery
Psoriasis-type or linear morphea, and PUVA is considered to be one of the best treatment options available.
Severe cases of morphea with elevated ANA and other autoantibody levels have been improved with the use of plasmapheresis.
You may want to discuss these options with your personal physician.
Followup with your personal physician is
essentialEssential hypertension
Essential tremor.
This answer is not intended as and does not substitute for medical advice - the information presented is for
patientKidney diet - dialysis patients education only. Please see your personal physician for further evaluation of your individual case.
Kevin, M.D.
Medical Weblog:
kevinmd_b
www.4life.com
www.transferfactor.com
If you have any questions and want more details about TF email me at
***@****